Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease (Q43533865)

24 November 2017

title

Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease (English)

1 reference

24 November 2017

9

1 reference

24 November 2017

Natàlia Ferré

1

1 reference

24 November 2017

Mònica Tous

2

1 reference

24 November 2017

Antoni Paul

3

1 reference

24 November 2017

Alberto Zamora

4

1 reference

24 November 2017

Juan J Vendrell

5

1 reference

24 November 2017

Alfredo Bardají

6

1 reference

24 November 2017

Jordi Camps

7

1 reference

24 November 2017

Cristobal Richart

8

1 reference

24 November 2017

publication date

1 May 2002

1 reference

24 November 2017

published in

Clinical Biochemistry

1 reference

24 November 2017

volume

35

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

197-203

1 reference

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Antioxidative activity of high density lipoproteins in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Mutations in the human paraoxonase 1 gene: frequencies, allelic linkages, and association with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Influence of the human paraoxonase polymorphism (PON1 192) on the carotid-wall thickening in a healthy population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

The Met54Leu polymorphism of paraoxonase (PON) enzyme gene is not a genetic risk factor for non-insulin-dependent diabetes mellitus in Finns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Genetic variations of the paraoxonase gene in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Lipoprotein(a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

The molecular basis of the human serum paraoxonase activity polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Genetic dissection of complex traits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase activity in two healthy populations with differing rates of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Paraoxonase Polymorphism (Gln192Arg) as a Determinant of the Response of Human Coronary Arteries to Serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

The antioxidant potential of the Mediterranean diet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Does paraoxonase play a role in susceptibility to cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900295-3

10.1016/S0009-9120(02)00295-3

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference